Morphine Rectal and Osimertinib: Interaction Details
- Morphine Rectal
- RMS SuppositoryInfumorphMitigo +3 more
- Osimertinib
- Tagrisso
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Morphine Rectal and Osimertinib interaction:
Morphine Rectal
- RMS Suppository
- Infumorph
- Mitigo
- Duramorph
- MS Contin
- Kadian
What Happens When You Take Morphine Rectal With Osimertinib
What can happen when they are taken together (rated Major)
Increased morphine exposure and an increased risk of morphine-related adverse effects (, , profound , coma)
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
Taking morphine together with a can raise morphine exposure by roughly 2-fold, which heightens the risk of adverse effects such as respiratory and . When the two drugs must be given together, patients should be observed for signs of CNS depression. They should also be assessed for respiratory depression that could be more pronounced than would normally be anticipated, and the dose of morphine and/or the P-gp inhibitor should be lowered if needed.1432
The Morphine Rectal and Osimertinib Interaction, Explained
Osimertinib (Tagrisso) may raise the amount of morphine in your body. It can block a pump () that helps move morphine out of cells, so morphine could build up, possibly to about double the usual exposure. This could mean more drowsiness, slowed breathing, low blood pressure, or, in rare serious cases, coma. This is based on theory, not on proven cases with this exact pair.
Don't change anything on your own. Your pharmacist or doctor can adjust your morphine dose and watch you more closely, so this combination can be used safely when needed.
Mechanism: Osimertinib is an in vitro (ABCB1) ; morphine is a P-gp . of efflux may increase morphine exposure (approx. 2-fold) and the risk of and , , profound , and coma. Morphine is active itself (its glucuronide also contribute), so higher exposure means greater effect.
- Evidence: theoretical; onset unspecified; severity on file: major.
- Management: if is required, monitor for and for respiratory depression greater than expected. Decrease the dose of morphine and/or the P-gp inhibitor as necessary, individualizing therapy.
See the 4 references behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Morphine Rectal and Osimertinib Interact
The likely mechanism
of -mediated efflux transport by morphine
How to Manage the Morphine Rectal and Osimertinib Interaction
Your care team can manage this combination by tailoring doses and monitoring.
- Keep taking both medicines as prescribed. Don't stop or change doses yourself.
- Your team may monitor you more closely for excess sleepiness and slowed breathing.
- Your morphine dose (and/or the osimertinib dose) may need to be adjusted and individualized by your care team.
- Tell your pharmacist or prescriber about unusual drowsiness, confusion, slow or shallow breathing, or dizziness right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Morphine Rectal or Osimertinib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Morphine Rectal and Osimertinib: Common Questions
How serious is the Morphine Rectal and Osimertinib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Morphine Rectal and Osimertinib interaction managed?
Your care team can manage this combination by tailoring doses and monitoring. Keep taking both medicines as prescribed. Don't stop or change doses yourself. Your team may monitor you more closely for excess sleepiness and slowed breathing. Your morphine dose (and/or the osimertinib dose) may need to be adjusted and individualized by your care team. Tell your pharmacist or prescriber about unusual… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
Ask About the Morphine Rectal and Osimertinib Interaction
Ask in your own words about taking Morphine Rectal and Osimertinib together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (4)
- Product Information: MS CONTIN(R) oral extended-release tablets, morphine sulfate oral extended-release tablets. Purdue Pharma LP (per FDA), Stamford, CT, 2023. DailyMed
- Product Information: Morphine sulfate oral tablets, morphine sulfate oral tablets. Hikma Pharmaceuticals USA Inc.(Per FDA), Berkeley, NJ, 2023. DailyMed
- Product Information: Morphine sulfate oral solution, morphine sulfate oral solution. Hikma Pharmaceuticals USA Inc (per FDA), Berkeley Heights, NJ, 2023. DailyMed
- Product Information: KADIAN(R) oral extended-release capsules, morphine sulfate oral extended-release capsules. Allergan USA, Inc (per FDA), Madison, NJ, 2019. DailyMed
Other Serious Interactions of Morphine Rectal and Osimertinib
Also serious with Morphine Rectal
- IsocarboxazidContraindicated
- LinezolidContraindicated
- Methylene BlueContraindicated
- NaltrexoneContraindicated
Also serious with Osimertinib
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, as soon as they can.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks.
- UnspecifiedThe timing of this interaction is not well characterized. This interaction.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.